Frederick H. Neill

Baylor College of Medicine — United States

Medicine · Health Sciences

29h-index5.9kcitations59works5.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral gastroenteritis research and epidemiology(59), Animal Virus Infections Studies(40), Virus-based gene therapy research(24), Viral Infections and Immunology Research(13), Hepatitis Viruses Studies and Epidemiology(7)

Publications59 total

Functional diversity in GII.4 norovirus entry: HBGA binding and capsid clustering dynamics
Proceedings of the National Academy of Sciences·2025· 2 citedOpen Access
Functional Diversity in GII.4 Norovirus Entry: HBGA Binding and Capsid Clustering Dynamics
2025Open Access
2′-Fucosyllactose inhibits human norovirus replication in human intestinal enteroids
Journal of Virology·2025· 9 citedOpen Access
A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies
Carolina Digital Repository (University of North Carolina at Chapel Hill)·2024Open Access
Lack of Detection of Norwalk Virus in Saliva Samples From a Controlled Human Infection Model
Open Forum Infectious Diseases·2024Open Access
Insights into human norovirus cultivation in human intestinal enteroids
mSphere·2024· 29 citedOpen Access
Bile acid-sensitive human norovirus strains are susceptible to sphingosine-1-phosphate receptor 2 inhibition
Journal of Virology·2024· 8 citedOpen Access
Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen–Blocking Antibody Levels
The Journal of Infectious Diseases·2024· 2 cited
2’-Fucosyllactose Inhibits Human Norovirus Replication in Human Intestinal Enteroids
2024· 2 citedOpen Access
Insights into Human Norovirus Cultivation in Human Intestinal Enteroids
2024· 4 citedOpen Access
Bile acid-sensitive human norovirus strains are susceptible to sphingosine-1-phosphate receptor 2 inhibition
2024· 2 citedOpen Access
A single nanobody neutralizes multiple epochally evolving human noroviruses by modulating capsid plasticity
Nature Communications·2023· 29 citedOpen Access
Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity
Antimicrobial Agents and Chemotherapy·2023· 24 citedOpen Access
A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies
The Journal of Infectious Diseases·2023· 14 cited
Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response
npj Vaccines·2023· 10 citedOpen Access
Intra- and Inter-host Evolution of Human Norovirus in Healthy Adults
2023· 3 citedOpen Access
A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide
2023· 2 citedOpen Access
CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection
Nature Communications·2023· 47 citedOpen Access
Antiviral Activity of Olanexidine-Containing Hand Rub against Human Noroviruses
mBio·2022· 20 citedOpen Access
Association of Secretor Status and Recent Norovirus Infection With Gut Microbiome Diversity Metrics in a Veterans Affairs Population
Open Forum Infectious Diseases·2022Open Access
page 1 of 3Next →

Frequent Co-authors

Robert L. Atmar(49), Mary K. Estes(46), Sue E. Crawford(19), Khalil Ettayebi(18), Sasirekha Ramani(18), B. Vijayalakshmi Ayyar(15), Victoria R. Tenge(12), Xi‐Lei Zeng(8), David Y. Graham(8), B. V. Venkataram Prasad(8), Antone R. Opekun(7), Umesh C. Karandikar(5), Kellogg J. Schwab(5), F. Le Guyader(5), Wilhelm Salmen(5), Ketki Patil(5), Kosuke Murakami(4), Sarah E. Blutt(4), Mark A. Gilger(4), Theodore G. Metcalf(4)